From: The outcomes of chemotherapy only treatment on mild spinal tuberculosis
Variable | Value (%) | |
---|---|---|
Sex | ||
Male | 34 (52) | |
Female | 55 (48) | |
Age (years) | ||
15–40 | 43 (48.3) | |
41–60 | 35 (39.3) | |
>60 | 11 (12.4) | |
Symptoms at presentation | ||
Pain | 87 (97.75) | |
Night sweat | 33 (37.08) | |
Low temp fever | 25 (28.09) | |
Marasmus | 39 (43.82) | |
Physical signs | ||
Restriction | 80 (89.89) | |
Percussion pain | 88 (98.88) | |
Local deformity | 10 (11.24) | |
Sinus | 2 (2.25) | |
ESR (mm/h) | 42.35 ± 6.31 | |
Drug-resistant tests | 31 | |
Sensitive | 15 (48.39) | |
Resistant | 4 (12.09) | |
Numbers of involved vertebra | ||
1 | 5 (5.62) | |
2 | 78 (87.64) | |
3 | 6 (6.74) | |
Imaging appearance | ||
Disc space destruction | 81 (91.01) | |
Paravertebral abscess | 56 (62.92) | |
Local kyphosis | 69 (77.53) | |
Vertebral body destruction | 84 (94.38) | |
Affected spinal level | ||
Cervical | 2 (2.2) | |
Thoracic | 21 (23.6) | |
Thoracolumbar | 14 (15.7) | |
Lumbar | 50 (56.2) | |
Sacral | 2 (2.2) | |
Neurological signs | ||
Pretreatment (ASIA D) | 11 (12.4) | |
Posttreatment (ASIA D) | 6 (6.7) | |
Pretreatment (ASIA E) | 78 (87.6) | |
Posttreatment (ASIA E) | 83 (93.3) | |
Kyphosis (°) | ||
Pretreatment | 6.2 ± 3.11° | |
Posttreatment | 14.36 ± 6.31° | |
Mean VAS score | ||
Pretreatment | 7.6 | |
Posttreatment (12M) | 1.7 | |
Posttreatment (24M) | 0 |